1. Home
  2. ONC vs VRSN Comparison

ONC vs VRSN Comparison

Compare ONC & VRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • VRSN
  • Stock Information
  • Founded
  • ONC 2010
  • VRSN 1995
  • Country
  • ONC Switzerland
  • VRSN United States
  • Employees
  • ONC N/A
  • VRSN N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • VRSN EDP Services
  • Sector
  • ONC Health Care
  • VRSN Technology
  • Exchange
  • ONC Nasdaq
  • VRSN Nasdaq
  • Market Cap
  • ONC 31.5B
  • VRSN 27.1B
  • IPO Year
  • ONC N/A
  • VRSN 1998
  • Fundamental
  • Price
  • ONC $299.01
  • VRSN $265.37
  • Analyst Decision
  • ONC Strong Buy
  • VRSN Strong Buy
  • Analyst Count
  • ONC 9
  • VRSN 2
  • Target Price
  • ONC $332.44
  • VRSN $277.50
  • AVG Volume (30 Days)
  • ONC 411.4K
  • VRSN 955.6K
  • Earning Date
  • ONC 08-06-2025
  • VRSN 07-24-2025
  • Dividend Yield
  • ONC N/A
  • VRSN 1.16%
  • EPS Growth
  • ONC N/A
  • VRSN 0.29
  • EPS
  • ONC N/A
  • VRSN 8.38
  • Revenue
  • ONC $4,175,868,000.00
  • VRSN $1,598,200,000.00
  • Revenue This Year
  • ONC $865.19
  • VRSN $8.00
  • Revenue Next Year
  • ONC $21.12
  • VRSN $2.73
  • P/E Ratio
  • ONC N/A
  • VRSN $31.67
  • Revenue Growth
  • ONC 51.16
  • VRSN 4.59
  • 52 Week Low
  • ONC $155.75
  • VRSN $172.49
  • 52 Week High
  • ONC $308.87
  • VRSN $310.60
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • VRSN 37.31
  • Support Level
  • ONC N/A
  • VRSN $263.94
  • Resistance Level
  • ONC N/A
  • VRSN $310.60
  • Average True Range (ATR)
  • ONC 0.00
  • VRSN 7.00
  • MACD
  • ONC 0.00
  • VRSN -2.77
  • Stochastic Oscillator
  • ONC 0.00
  • VRSN 3.06

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About VRSN VeriSign Inc.

VeriSign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Share on Social Networks: